Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Pooled data suggest dual antiplatelet therapy (DAPT) may lower the risk of all-cause death in MINOCA patients, but it does not appear to reduce heart attacks or major adverse…
Autologous pericardial annuloplasty is associated with a significantly lower rate of moderate tricuspid regurgitation recurrence at 48 and 96 months compared to prosthetic ring…
The TWEAK-Fn14 axis is implicated in several pathological processes in the heart, including inflammation, hypertrophy, and fibrosis.
Traditional Chinese Medicine (TCM) shows promise in research for treating myocardial fibrosis by targeting specific cellular pathways and improving mitochondrial health.
Yes. Studies generally find lower vitamin D levels in people with Graves' disease than in healthy controls, though the gap is modest and one study's deficiency-risk estimate was…
Yes, a 2026 randomized trial found that a scoring paclitaxel-coated balloon improved 6-month target lesion patency of failing arteriovenous fistulas compared with a plain balloon…
Yes. A 2026 multicenter randomized trial found that a scoring paclitaxel-coated balloon improved 6-month target lesion primary patency (78.9% vs 57.3%) compared with plain…
Self-management programs for arteriovenous fistulas (AVFs) can include physical therapy, respiratory exercises, and programs based on various behavioral and nursing theories.
Beta-blockers may help preserve heart pumping function in some cancer patients receiving cardiotoxic chemotherapy, but the evidence is mixed and depends on the cause and setting…
The biggest risk factor for trastuzumab-induced cardiotoxicity is prior anthracycline chemotherapy; other risks include older age, existing heart disease, high blood pressure…
Small pilot trials in STEMI patients suggest ticagrelor monotherapy right after primary PCI may reduce bleeding without a clear rise in ischemic events, but the evidence is too…
Yes. A large randomized trial found that a pressure optimization protocol during primary PCI for STEMI improved reperfusion success compared with conventional rapid…
Yes. Primary aldosteronism is consistently linked to lower blood potassium levels, and the drop is larger in more severe or unilateral cases [1][2][6].
In-stent restenosis after vertebral artery ostial stenting occurs in about 13.5% to 37.2% of cases, depending on the study and follow-up duration.
About half of patients develop acute kidney injury after type A aortic dissection surgery, with higher risk in older patients, those with renal malperfusion, and longer bypass…
Immune interactions, particularly involving T cells and the communication between vascular smooth muscle cells and immune cells, play a significant role in driving tissue…
People with SDHD mutations are frequently associated with multifocal tumors, which can include multiple pheochromocytoma or paraganglioma sites.
GLP-1 receptor agonists reduce major adverse limb events (MALE) and cardiovascular risks in people with type 2 diabetes and peripheral artery disease, based on meta-analyses.
Yes, GLP-1 receptor agonists reduce major limb events in patients with type 2 diabetes and peripheral artery disease, with a 27% lower risk shown in a 2026 meta-analysis.
Yes, tirzepatide may reduce major adverse limb events and cardiovascular risks in people with PAD, but direct trial data are still limited.
Incretin analogues (GLP-1 RAs) reduce cardiovascular risk in PAD by improving walking distance, lowering inflammation, and decreasing heart attack and stroke events.
SGLT2 inhibitors may lower all-cause mortality in transthyretin cardiomyopathy, but evidence is mixed; one study shows benefit, another shows no mortality reduction when added to…
Yes, furosemide plus hypertonic saline is linked to lower increases in biomarkers like NT-proBNP, IL-6, and sST2 after a saline load in ADHF patients, though baseline reductions…
Yes, natriuresis-guided protocols increase weight loss in acute decompensated heart failure, with a meta-analysis showing about 0.45 kg more weight loss at 48 hours compared to…
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.